‹ Cerebras Systems
Ch 5 · The Story Behind the Numbers
Chapter 5 · Behind the Numbers
The numbers, in the company's own words.
Cerebras’s IPO prospectus, in plain English — the growth, the concentration, and the bets.
↓ scroll to read
✦ The bottom line
Anyone can read the revenue line. The story — what’s fueling the growth and what’s propping it up — is the part Cerebras spells out in its prospectus.
↓ the brief below
Seven threads from the IPO prospectus
1
Revenue is compounding at a startling rate.
FY2025 revenue reached $510 million, up 76% — and 20× the $25M of just three years earlier ($25M → $79M → $290M → $510M).
2
But 86% of it comes from the UAE.
Two UAE customers — G42 and the Abu Dhabi AI university MBZUAI — drove 86% of 2025 revenue. That concentration is the single biggest risk in the prospectus.
3
The “profit” is real but accounting-driven.
GAAP net income swung to a $237.8M profit from a $481.6M loss — but strip out stock-comp and a forward-contract gain and the business ran a $75.7M non-GAAP loss. Still pre-profit underneath.
4
An architectural moat you can measure.
Cerebras’s WSE-3 wafer-scale chip is ~58× the silicon area of an Nvidia B200 — a genuinely different bet on how to build AI compute.
5
OpenAI is the headline validator.
A multi-year framework agreement with OpenAI for fast inference is the prospectus’s marquee proof that the architecture wins real frontier work.
6
AWS brings distribution at scale.
An AWS partnership is the channel story — putting Cerebras inference in front of enterprise buyers it couldn’t reach alone.
7
One customer owes most of the money.
At year-end, MBZUAI alone accounted for 77.9% of receivables — concentration that shows up on the balance sheet, not just the income statement.
Source · 424B4 · Prospectus Summary / Risk Factors / Business · as of IPO · Filed May 14, 2026
Read the whole story
Seven threads the prospectus is telling — startling growth, deep customer concentration, an architectural moat, and two marquee partners.
You just finished
Chapter 5 · BEHIND THE NUMBERS
The Story Behind the Numbers
you now read: reading the MD&A
Up next